Mergers and Acquisitions in the IVD Market
Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.
- Executive Summary
- The Market Landscape
- Mergers and Acquisitions
- Methodology
- IVD Mergers and Acquisitions
- Introduction
- Table Selected Acquisitions of Diagnostic Companies, 2015-2016
- Select Top Tier IVD Company Activities in 2015 and 2016
- The Proposed Acquisition of Alere by Abbott
- Roche Remains Active in M&A
- Siemens' Plan to Divest Its Healthcare Business, Siemens Healthineers
- Danaher's Acquisition of Molecular Diagnostics Leader Cepheid
- Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength
- Thermo Fisher Scientific Acquires Affymetrix
- Beckman Coulter Acquires Siemens Healthcare Diagnostics' Clinical Microbiology Business
- Becton Dickinson (BD) Prepares Its Entrance into Sequencing with Cellular Research Acquisition
- Other 2015-2016 Acquisitions of Note
- Luminex's Acquisition of Nanosphere
- Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal
- IBM Healthcare/Watson Continues Expansion
- Select 2013-2014 Acquisitions of Note
- Abbott Diagnostics
- Johnson and Johnson (J&J)
- Thermo Fisher
- Table Selected Acquisitions of Diagnostic Companies, 2013-2014
- Becton Dickinson
- bioMérieux
- Bio-Rad Laboratories
- Arkray
- QIAGEN
- Radiometer
- Trinity Biotech
- Grifols International
- Introduction
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook